Albemarle Corporation EBITDA for the Trailing 12 Months (TTM) ending June 30, 2025: USD -802.61 M

Albemarle Corporation EBITDA is USD -802.61 M for the Trailing 12 Months (TTM) ending June 30, 2025, a -26.21% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
  • Albemarle Corporation EBITDA for the Trailing 12 Months (TTM) ending June 30, 2024 was USD -1.09 B, a -130.96% change year over year.
  • Albemarle Corporation EBITDA for the Trailing 12 Months (TTM) ending June 30, 2023 was USD 3.51 B, a 580.34% change year over year.
  • Albemarle Corporation EBITDA for the Trailing 12 Months (TTM) ending June 30, 2022 was USD 516.40 M, a -32.50% change year over year.
  • Albemarle Corporation EBITDA for the Trailing 12 Months (TTM) ending June 30, 2021 was USD 765.08 M, a -6.86% change year over year.
Key Data
Date EBITDA Net Income EPS (Diluted) Shares (Diluted, Weighted)